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Abstract: residues in sodium ampicillin (AMP) in eggs of laying hens were determined by a 
microbiological method of diffusion in agar after oral therapy with an esophageal probe with a dose of 
150 mg / kg / day for 5 days. The limit of quantification is 0.02 µg / g in albumen and yolk. The 
duration of the elimination of AMP in the albumen and yolk is 2 days after stopping the treatment. 
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                                                     INTRODUCTION  
 
The harm of some diseases of microbial origin and superinfection in microbial 
component fully justifies the wide use of antibiotics in laying hens. The conditions of factory 
farming and the concentration of animals caused by a viable colony high and increased 
virulence of microorganisms and increases epidemiology. The antibiotic also has two major 
drawbacks:  
The creation of antibiotic-resistant bacterial strains in laying hens.  
The possibility of contamination of the egg residues, whose impact on human health 
may be of concern, either because of toxic effects of antibiotics, either because of the risk of 
antibiotic-resistant germs selection [8]. This investigative work aims to help find possible 
residue of AMP sodium in albumin and yolk of the egg after oral administration with an 
esophageal probe.   
 
MATERIAL AND METHODS 
 
Breeding conditions: The work has been achieved in the the Regional Veterinary 
laboratory of Tizi Ouzou on 20 laying hens bred ISABROWN, with an average weight of 1.9 
kg, divided into 2 groups (experimental and control), in an animal at room temperature (22 ° 
C), day length was 14 hours / day. The birds aged 52 weeks received a diet based on "laying 
flour high-energy free of antibiotics, and water at will.  
Experimentation: AMP sodium was administered daily at the same time, using an 
esophageal probe with a dose of 150 mg / kg / day for 5 days. The eggs of each batch of 
chickens were collected daily. For the purposes of the study, three eggs were randomly 
selected from each batch. Each of these three eggs are treated separately. The albumen and 
yolk of each egg were separated and 03 samples of each matrix were removed, weighed and 
analyzed until eggs no longer contain detectable residues of AMP sodium.  
Analytical Methods: Measurement of AMP residues in eggs was done using general 
microbiological methods described in the literature [2] to tissues [6] or the egg [3,5,1]. 
Sample preparation: Each array (albumen and yolk) was diluted separately in third in 
a phosphate buffer at pH 6 ± 0.1 percent (Table 1) and homogenized using a Sorvall mixer. 
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The samples were kept in a freezer at (-18 ° C) to their treatment. For the yolk improved the 
limit of quantification was obtained by centrifugation after freezing the yolk mixture - buffer 
5000 rpm for 15 minutes. The heat treatment of the mixture albumen - buffer was performed 
at 70 ° C for 15 minutes. 
Petri dish preparation: After inoculation of an agar medium (Antibiotic 8 Difco 
agar) with a suspension of Sarcina lutea ATCC 9341 [4,5,2] with a final concentration of 103 
organisms / ml. 17 bowls (8 mm diameter) were dug on the agar, 08 bowls were filled with 
0.2 ml of sample solution at different concentrations, the 08 other bowls are reserved to the 
reference range and a bowl to witness. 
The standard curve: standard curves were made by adding to the albumen and yolk 
indicator light (test taken 10 g) 1 ml of sodium increasing concentration of AMP (Sigma) 
diluted to 1 / 3 by adding 19 ml of a phosphate buffer at pH 6 ± 0.1 percent (Table 1) and 
mixing, the solutions obtained correspond to different points of range or 4 concentrations of 
the reference range (0.16,0.08, 0.04 and 0.02 µg / g) for  albumen (Table 4, Figure 1) and four 
concentrations (0.16,0.08, 0.04 and 0.02 mg / g) for the yolk (Table 5, Figure 2). Petri dishes 
(120 x 120 mm) are incubated for 18 hours at  37 °C. The reading of the diameter of 
inhibition zones was made using a ruler and a magnifying glass illuminating 
 
Table 1 
 
Values of pH of the albumen and yolk diluted in phosphate buffer at pH6. 
Matrix phosphate buffer pH 6 ± 0.1 
Albumen (pH = 7.9) 6.6 
Yolk (pH = 6.4) 6.2 
 
RESULTS AND DISCUSSION  
 
Lot of digital data were collected daily and are "raw data" (Table 2.3). For a dose 
equal to 150 mg / kg / day administered for 5 days orally using an esophageal probe, AMP 
sodium residues are detected on the first day in the albumen and the second day in yolk 
during treatment. AMP sodium residues persist until the second day in the yolk and they will 
no longer be detected in the albumen after the end of treatment (Table 6, Figure 3). Residues 
of the AMP longer are present in the yolk than in the albumen (two days), but their onset is 
faster in the latter (24 hours for 48 hours albumen cons to the yolk). Indeed, if the residues 
reach the level of the genital tract, they can permeate the egg albumen in training, which will 
probably be yellow "protected" from contamination by the membrane sac. It was not until 
ovulation the oocyte "the most mature, contaminated the ovary, to observe traces of 
antibiotics in the latter [8]. The results are consistent with the mechanisms involved at the 
time of egg formation in the ovary and with the respective sites of yolk synthesis (liver) and 
albumen (oviduct) [4]. The study by Roudaut (1987) at a dose (150 mg / kg) showed that 
residues were detectable in the albumen as well as in the yolk during and even after the 
treatment period. Maximum concentrations were obtained at 4th day after beginning treatment 
for albumen (0,008 µg / g), yolk (0,028 µg / g) and whole egg (0,015 µg/g) and then 
decreased rapidly from the last day of treatment. 
Our study of the same dose such as (150 mg / kg) showed maximum concentrations in 
the albumen with the 2nd day (0,038 µg / g) and 4th day in the yolk with (0,041µg /g) and 
egg whole day with the 3rd (0,037 µg / g) and then they decrease rapidly from the 2nd day 
after discontinuation of treatment and the yolk from the last day of treatment for the albumen 
and whole egg. A comparison of the results reveals that the highest concentrations obtained in 
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our experiments are five times higher in the albumen and almost double for the yolk. The 
method used orally using an esophageal probe could explain this discrepancy results.   
 
Table 2  
 
Diameters of inhibition zones (mm) obtained during the treatment of 150 mg / kg of Ampicillin orally. 
 
 
Legend: Samp: Sample, YOL: Yolk, ALB: Albumen, UND: undetectable. 
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Figure 1: Standard curve of AMP in the albumen 
 
             DURING TREATMENT 
Time in days  1 2 3 4 5 
YOL UND UND 12.47 11.37 9.46 
Samp .1 ALB. 
 
UND 10.82 9.68 UND 10.90 
YOL UND 9.64 12.42 10.65 9.97 
Samp.2 
ALB. 10.66 11.11 UND 10.92 UND 
YOL UND 9.89 12.15 11.93 10.23 
 
 
 
 
 
 
 
 
 
 
 
 
Eg
g 
1 
 
Samp .3 
ALB. UND 11.06 9.44 UND UND 
YOL UND 10.30 11.94 12.59 10.65 
Samp .1 ALB. 
 
10.86 10.63 10.09 11.12 10.71 
YOL UND 10.81 11.68 10.92 11.18 
Samp .2 
ALB. 9.54 10.40 10.58 9.78 10.47 
YOL UND 11.05 11.13 12.42 11.43 
Eg
g 
 
2 
Samp 3 
ALB. UND 9.91 10.82 UND 
 
9.98 
YOL UND 11.50 10.42 12.64 11.89 
Samp .1 ALB. 
 
10.43 9.52 11.02 10.69 9.58 
YOL UND UND 9.88 12.20 11.94 
Samp .2 
ALB. UND UND 11.26 9.53 UND 
YOL. UND 11.25 10.69 10.10 11.63 
Eg
g 
 
3 
Samp .3 
ALB. 9.94 UND UND 10.18 UND 
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Table 3 
  
Diameters of inhibition zones (mm) obtained after treatment of 150 mg / kg of ampicillin orally 
                                 
Legend: Sample, YOL: YOLK, ALB: Albumen, UND: Not detectable, UND: undetectable. 
                                                                                                                            
                                          Table 4 
Diameters of inhibition zones (mm) obtained with the concentrations of the standard curve of the AMP in the 
albumen   
Concentration  (µg /g) Diameters of inhibition zones (mm) Middle 
0.16 15.00 15.50 16.17 16.00 15,67 
0.08 12.40 12.07 12.40 11.80 12.17 
0.04 10.17 9.90 10.06 9.74 9.97 
0.02 9.21 9.20 9.11 9.11 9.16 
 
Table 5 
Diameters of inhibition zones (mm) obtained with the concentrations of the standard range of AMP in the yolk. 
Concentration   (µg /g) Diameters of inhibition zones (mm) Middle 
0.16 16.00 16.40 17.89 15.30 16.40 
0.08 14.00 14.47 13.74 15.67 14.47 
0.04 11.40 11.50 11.30 11.80 11.50 
0.02 9.31 9.23 9.22 9.15 9.23 
When stopping the treatment.                     Treatment   
Time in days 
1 2 3 4 5 6 7 8 9 10 
YOL 11.59 10.30 UND UND UND UND ND ND ND ND 
Samp1 ALB. 
 
UND UND UND UND UND UND ND ND ND ND 
YOL . 11.54 9.64 UND UND UND UND ND ND ND ND 
Samp.2 
ALB. UND UND UND UND UND UND ND ND ND ND 
YOL . 11.29 10.81 UND UND UND UND ND ND ND ND 
Eg
g 
 
1 
Samp.3 
ALB. UND 9.50 UND UND UND UND ND ND ND ND 
YOL . 11.09 11.50 UND UND UND UND ND ND ND ND 
Samp 1 ALB. 
 
UND UND UND UND UND UND ND ND ND ND 
YOL . 10.85 UND 9.72 UND UND UND ND ND ND ND 
Samp.2 
ALB. UND UND UND UND UND UND ND ND ND ND 
YOL . 10.34 1.25 9.93 UND UND UND ND ND ND ND 
Eg
g 
 
2 
Samp.3 
ALB. UND UND UND UND UND UND ND ND ND ND 
YOL . 9.68 11.54 10.33 UND UND UND ND ND ND ND 
Samp.1 ALB. 
 
9.58 UND UND UND UND UND ND ND ND ND 
YOL . UND 11.05 10.37 UND UND UND ND ND ND ND 
Samp.2 
ALB. 9.79 UND UND UND UND UND ND ND ND ND 
YOL . 9.93 UND 10.11 UND UND UND ND ND ND ND 
Eg
g 
 
3 
Samp.3 
ALB. 9.83 UND UND UND UND UND ND ND ND ND 
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Figure 2: Standard curve of AMP in the yolk 
 
Table 6 
 
Residues of the AMP (mg / g) in albumen, yolk and whole egg during and after oral treatment (150 mg / kg) for 
5 days 
DURING TREATMENT AFTER THE END  OF TREATMENT  
Time in days 1 2 3 4 5 1 2 3 4 5 
ALBUMEN 0.024 0.038 0.036 0.031 0.025 <0.02 <0.02 UND UND UND 
Standard deviation 0.006 0.026 0.015 0.011 0.019      
YOLK UND 0.024 0.038 0.041 0.033 0.028 0.025 <0.02 UND UND 
Standard deviation  0.008 0.011 0.004 0.009 0.011 0.001    
WHOLE EGG  0.017 0.034 0.037 0.033 0.028 0.017 0.010 UND UND UND 
Standard deviation 0.004 0.017 0.009 0.009 0.013 0.009 0.004    
Legend: UND; Not detected, albumen and yolk: with a sensitivity limit of 0.02 µg / g. 
 
 
Figure 3: Evolution of the concentration of AMP (µg / g) in albumen, yolk and whole egg during and after 
treatment administered orally (oesophageal probe: 150 mg / kg / day for 5 days. 
 
 
 
 
 
 
 
 
 
0
0.01
0.02
0.03
0.04
0.05
1 2 3 4 5 1 2 3
Time (days)co
n
ce
n
tr
at
io
n
 
(µg
/g
)
Albumen
Yolk
Whole egg
During treatment              After treatment 
 385 
Table 7 
The proposed  withdrawal 
Administration of   AMP through oral voice 150 mg / kg / day for 5 days Constituents of the egg 
 Residues detectable   waiting time 
Albumen + (0 day) (0 day) 
Yolk + (2 days ) + (2 days) 
Whole egg + (2 days) + (2 days) 
  whole egg:  tolerance proposed  0.01 µg / g. 
 
 
CONCLUSIONS  
 
This study shows that there are real risks of contamination of the egg constituents by 
residues of the AMP sodium in the laying hen. We must therefore define a delay before 
delivery of each constituent of the egg to ensure product quality provided to customers 
(industrial food processing and pharmacies). It appears so urgent that safety standards can be 
defined for each antibiotic used on the national level, so that the farmer can continue to 
benefit from this therapy without the consumer's health at risk is unacceptable.   
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